Skip to content
Screener

Fulgent Genetics, Inc. FLGT Laboratory Services — Revenue

Other segment segments

Therapeutic Development
$87K

Similar metrics at other companies

Insight Molecular Diagnostics Inc. logo
IMDXLaboratory Services — Revenue
$218K-55.9%
Labcorp Holdings logo
LHBiopharma Laboratory Services — Revenue
$780.6M+8.2%
Aclaris Therapeutics logo
ACRSLaboratory Research Revenue — Revenue
$356K-19.5%
Consolidated Water Company logo
CWCOServices Revenues — Revenue
$11.59M+1.2%
Ribbon Communications Inc. logo
RBBNService Revenue Professional Services — Revenue
$30.83M-6.2%
GigaCloud Technology logo
GCTService revenues — Revenue
$120.83M+24.7%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Three Months Ended March 31, 2026Laboratory ServicesTherapeutic DevelopmentTotal
Revenue$71,051$87$71,138
Less:
Adjusted cost of revenue48,179848,187
Adjusted research and development6,4614,17810,639
Adjusted selling and marketing11,57611,576
Adjusted general and administrative20,05235720,409
Total adjusted operating loss$(15,217)$(4,456)$(19,673)

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s laboratory services — revenue?
Fulgent Genetics, Inc. (FLGT) reported laboratory services — revenue of $71.05M in Q1 2026.
How has Fulgent Genetics, Inc.'s laboratory services — revenue changed year-over-year?
Fulgent Genetics, Inc.'s laboratory services — revenue decreased by 3.3% year-over-year, from $73.46M to $71.05M.
What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — revenue?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s laboratory services — revenue has grown at a -24.5% compound annual growth rate (CAGR), from $992.58M to $322.22M.
What does laboratory services — revenue mean?
This represents the total gross income generated from the provision of laboratory diagnostic and interpretation services, excluding assessed taxes. It is the primary measure of the scale and commercial success of the company's core laboratory operations.

Ask your AI about Fulgent Genetics, Inc.'s laboratory services — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude